Disseminating and Implementing the Science of Pediatric Obesity Treatment and Prevention

Amanda E Staiano1, Paul A Estabrooks2, Gabriela Buccini3

  • 1Pennington Biomedical Research Center, Baton Rouge, Louisiana, USA.

Insights

Leaders in dissemination and implementation science met to identify needs and strategies for rapidly implementing evidence-based pediatric obesity interventions in healthcare, schools, and communities.

Area of Science:

  • Dissemination and Implementation Science
  • Pediatric Obesity Prevention and Treatment

Background:

  • Leaders in dissemination and implementation science convened for a symposium.
  • The symposium focused on pediatric obesity prevention and treatment interventions.

Purpose of the Study:

  • Identify effective dissemination and implementation strategies.
  • Determine contextual factors for strategy selection.
  • Advance the science of translating evidence-based interventions into practice.

Main Methods:

  • Convened a scientific symposium with leaders in dissemination and implementation science.
  • Identified knowns and needs for rapid dissemination and implementation.
  • Focused on evidence-based, guideline-backed pediatric obesity interventions.

Main Results:

  • Summarized the state of scientific evidence on pediatric obesity interventions.
  • Identified exemplars of implementation-effectiveness trials.
  • Provided recommendations for dissemination and implementation.

Conclusions:

  • Accelerate the translation of evidence-based pediatric obesity interventions into practice.
  • Advance dissemination and implementation science in various settings.
  • Foster rapid adoption of effective interventions in clinical and community settings.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
558
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
414
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
445
Preventive Healthcare Services01:30

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
2.4K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
975